EDESA BIOTECH INC (EDSA) Fundamental Analysis & Valuation

NASDAQ:EDSA • CA27966L3065

3.61 USD
-0.66 (-15.46%)
At close: Mar 5, 2026
3.77 USD
+0.16 (+4.43%)
After Hours: 3/5/2026, 4:51:48 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This EDSA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EDSA. EDSA was compared to 520 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for EDSA as it has an excellent financial health rating, but there are worries on the profitability. EDSA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. EDSA Profitability Analysis

1.1 Basic Checks

  • In the past year EDSA has reported negative net income.
  • EDSA had a negative operating cash flow in the past year.
  • EDSA had negative earnings in each of the past 5 years.
  • EDSA had a negative operating cash flow in each of the past 5 years.
EDSA Yearly Net Income VS EBIT VS OCF VS FCFEDSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • EDSA's Return On Assets of -53.13% is in line compared to the rest of the industry. EDSA outperforms 47.50% of its industry peers.
  • With a decent Return On Equity value of -56.01%, EDSA is doing good in the industry, outperforming 62.88% of the companies in the same industry.
Industry RankSector Rank
ROA -53.13%
ROE -56.01%
ROIC N/A
ROA(3y)-135.86%
ROA(5y)-111.64%
ROE(3y)-205.71%
ROE(5y)-157.84%
ROIC(3y)N/A
ROIC(5y)N/A
EDSA Yearly ROA, ROE, ROICEDSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EDSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EDSA Yearly Profit, Operating, Gross MarginsEDSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. EDSA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for EDSA has been increased compared to 1 year ago.
  • The number of shares outstanding for EDSA has been increased compared to 5 years ago.
  • There is no outstanding debt for EDSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EDSA Yearly Shares OutstandingEDSA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
EDSA Yearly Total Debt VS Total AssetsEDSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

2.2 Solvency

  • An Altman-Z score of 20.83 indicates that EDSA is not in any danger for bankruptcy at the moment.
  • EDSA's Altman-Z score of 20.83 is amongst the best of the industry. EDSA outperforms 89.62% of its industry peers.
  • There is no outstanding debt for EDSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 20.83
ROIC/WACCN/A
WACCN/A
EDSA Yearly LT Debt VS Equity VS FCFEDSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 16.82 indicates that EDSA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 16.82, EDSA belongs to the top of the industry, outperforming 93.08% of the companies in the same industry.
  • A Quick Ratio of 16.82 indicates that EDSA has no problem at all paying its short term obligations.
  • The Quick ratio of EDSA (16.82) is better than 93.08% of its industry peers.
Industry RankSector Rank
Current Ratio 16.82
Quick Ratio 16.82
EDSA Yearly Current Assets VS Current LiabilitesEDSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. EDSA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.50% over the past year.
EPS 1Y (TTM)38.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 6.34% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y16.76%
EPS Next 2Y2.75%
EPS Next 3Y0.91%
EPS Next 5Y6.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EDSA Yearly Revenue VS EstimatesEDSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 200K 400K 600K 800K 1M
EDSA Yearly EPS VS EstimatesEDSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

0

4. EDSA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EDSA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDSA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDSA Price Earnings VS Forward Price EarningsEDSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDSA Per share dataEDSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.75%
EPS Next 3Y0.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EDSA Dividend Analysis

5.1 Amount

  • No dividends for EDSA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EDSA Fundamentals: All Metrics, Ratios and Statistics

EDESA BIOTECH INC

NASDAQ:EDSA (3/5/2026, 4:51:48 PM)

After market: 3.77 +0.16 (+4.43%)

3.61

-0.66 (-15.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-13
Earnings (Next)05-12
Inst Owners34.52%
Inst Owner Change6.12%
Ins Owners12.23%
Ins Owner Change4.59%
Market Cap30.07M
Revenue(TTM)N/A
Net Income(TTM)-7.82M
Analysts82.5
Price Target11.22 (210.8%)
Short Float %0.22%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.68%
Min EPS beat(2)-17.65%
Max EPS beat(2)39%
EPS beat(4)3
Avg EPS beat(4)7.14%
Min EPS beat(4)-17.65%
Max EPS beat(4)39%
EPS beat(8)6
Avg EPS beat(8)6.78%
EPS beat(12)10
Avg EPS beat(12)16.9%
EPS beat(16)14
Avg EPS beat(16)22.38%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)39.71%
EPS NQ rev (3m)8.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-32.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.15
P/tB 2.51
EV/EBITDA N/A
EPS(TTM)-1.15
EYN/A
EPS(NY)-1.82
Fwd EYN/A
FCF(TTM)-0.95
FCFYN/A
OCF(TTM)-0.95
OCFYN/A
SpS0
BVpS1.68
TBVpS1.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.13%
ROE -56.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-135.86%
ROA(5y)-111.64%
ROE(3y)-205.71%
ROE(5y)-157.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.82
Quick Ratio 16.82
Altman-Z 20.83
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next Y16.76%
EPS Next 2Y2.75%
EPS Next 3Y0.91%
EPS Next 5Y6.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.34%
OCF growth 3YN/A
OCF growth 5YN/A

EDESA BIOTECH INC / EDSA FAQ

What is the fundamental rating for EDSA stock?

ChartMill assigns a fundamental rating of 3 / 10 to EDSA.


Can you provide the valuation status for EDESA BIOTECH INC?

ChartMill assigns a valuation rating of 0 / 10 to EDESA BIOTECH INC (EDSA). This can be considered as Overvalued.


What is the profitability of EDSA stock?

EDESA BIOTECH INC (EDSA) has a profitability rating of 1 / 10.


Can you provide the financial health for EDSA stock?

The financial health rating of EDESA BIOTECH INC (EDSA) is 8 / 10.


Can you provide the expected EPS growth for EDSA stock?

The Earnings per Share (EPS) of EDESA BIOTECH INC (EDSA) is expected to grow by 16.76% in the next year.